InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Recombinant human TNF-α | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| Mouse Control IgG1 | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| THP1-Dual™ Cells | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| QUANTI-Blue™ | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| THP1-Dual™ KO-MyD88 Cells | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| RAW-Blue™ Cells | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| Anti-hIL-1β-IgG | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| Anti-hTNF-α-hIgA2 | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| IL-1α & IL-1β Reporter HEK 293 Cells | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| Recombinant human IL-1β | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| IL-10 Reporter HEK 293 Cells | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| HEK-Blue™ Detection | A Porphyromonas gingivalis hypothetical protein controlled by the type I-C CR... | 2024 | mSystems | Irfan M. et al. | DOI: 10.1128/msystems.01231-23 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | A Porphyromonas gingivalis hypothetical protein controlled by the type I-C CR... | 2024 | mSystems | Irfan M. et al. | DOI: 10.1128/msystems.01231-23 |
| Normocin™ - Antimicrobial Reagent | A Porphyromonas gingivalis hypothetical protein controlled by the type I-C CR... | 2024 | mSystems | Irfan M. et al. | DOI: 10.1128/msystems.01231-23 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | A Porphyromonas gingivalis hypothetical protein controlled by the type I-C CR... | 2024 | mSystems | Irfan M. et al. | DOI: 10.1128/msystems.01231-23 |
| HEK-Blue™ Selection | A Porphyromonas gingivalis hypothetical protein controlled by the type I-C CR... | 2024 | mSystems | Irfan M. et al. | DOI: 10.1128/msystems.01231-23 |
| Blasticidin | Evolving precision: rRNA expansion segment 7S modulates translation velocity ... | 2024 | Nucleic Acids Res. | Rauscher R. et al. | DOI: 10.1093/nar/gkae067 |
| G418 (Geneticin) | Evolving precision: rRNA expansion segment 7S modulates translation velocity ... | 2024 | Nucleic Acids Res. | Rauscher R. et al. | DOI: 10.1093/nar/gkae067 |
| LPS-EB (LPS from E. coli O111:B4) | Ginger-derived bioactive compounds attenuate the toll-like receptor mediated ... | 2024 | Eur J Pharmacol. | Pázmándi K. et al. | DOI: 10.1016/j.ejphar.2024.176399 |
| Pam3CSK4 | Ginger-derived bioactive compounds attenuate the toll-like receptor mediated ... | 2024 | Eur J Pharmacol. | Pázmándi K. et al. | DOI: 10.1016/j.ejphar.2024.176399 |